Comparing Surgery Partners (NASDAQ:SGRY) & Its Rivals

Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its peers? We will compare Surgery Partners to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.

Risk and Volatility

Surgery Partners has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ peers have a beta of 1.47, suggesting that their average share price is 47% more volatile than the S&P 500.

Institutional and Insider Ownership

94.2% of Surgery Partners shares are owned by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 7.6% of Surgery Partners shares are owned by company insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Surgery Partners and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners 1 3 4 0 2.38
Surgery Partners Competitors 57 325 509 9 2.52

Surgery Partners currently has a consensus price target of $18.00, indicating a potential upside of 97.80%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 22.05%. Given Surgery Partners’ higher possible upside, equities research analysts clearly believe Surgery Partners is more favorable than its peers.

Profitability

This table compares Surgery Partners and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Surgery Partners -0.33% 1.03% 0.20%
Surgery Partners Competitors 3.52% 3.52% 4.31%

Valuation & Earnings

This table compares Surgery Partners and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Surgery Partners $1.15 billion $9.45 million -19.78
Surgery Partners Competitors $1.06 billion -$22.56 million 738.31

Surgery Partners has higher revenue and earnings than its peers. Surgery Partners is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Surgery Partners peers beat Surgery Partners on 8 of the 13 factors compared.

Surgery Partners Company Profile

Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.

Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply